In this episode of JCMS Author Interviews, host Kirk Barber speaks with Dr. Mohamed Abu-Hilal, a dermatologist and assistant professor at McMaster University, about his systematic review article on the maternal, fetal, and labor outcomes of Dupilumab use for atopic dermatitis during pregnancy. Dr. Abu Halal shares the motivations behind the study, discusses its findings, and addresses the safety and efficacy of dupilumab for pregnant patients suffering from eczema. The conversation covers the challenges in documenting cases, the reassuring results of live births, and the practical implications for dermatologists and patients. The episode emphasizes the importance of maintaining good maternal health for positive pregnancy outcomes and touches on the broader applications of dupilumab for other conditions.

This podcast is supported by an educational grant by Incyte Biosciences Canada, made available through the CDA Corporate Supporter Program.  

Dr Barber and his guests do not receive any financial reimbursement for the production of the podcast.

For more great CDA podcasts check out Dermalogues, our Residents podcast hosted by Dr Kerri Purdy.

To learn more about the work of the Canadian Dermatology Association, please visit our website at dermatology.ca

This podcast is produced by David McGuffin of ExploreProductions.ca